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Background
Receptors for the natriuretic peptides (NPs) ANP, BNP
a n dC N Pa r eh i g h l ye x p r e s s e di nl u n g ,s u g g e s t i n gt h a t
this organ is an important physiological target for NP sig-
nalling. By stimulating vaso- and bronchodilation and
inhibiting cell proliferation and fibrotic processes, NPs
may have therapeutic potential in various lung diseases.
Mechanisms responsible for the relatively short half-life
(few min) of NPs and the control of their local concen-
trations include (i) receptor-mediated internalization by
the so called clearance receptor (NPR-C) and (ii) degra-
dation by a membrane metalloprotease, called neutral
endopeptidase (NEP) or neprilysin (1). The velocity of
peptide degradation/inactivation differs between ANP,
BNP and CNP. Interestingly, cleavage of NPs by insulin-
degrading enzyme (IDE) (2) may have a particular role in
NP signalling by generating peptide fragments that are
hyperactive in receptor stimulation (3).
The physiological significance of NEP was supported by
several studies in rodents showing that NEP inhibition
leads to increased NP concentrations and activity. More-
over, we found that NEP inhibition is necessary and suffi-
cient for detection of GC-A and GC-B by affinity labelling
experiments with radioactive ANP or CNP in mouse and
rat lung membrane preparations. Analogous assays, how-
ever, failed to label these receptors in human lung mem-
branes, suggesting potent NP-degrading activity of NEP
inhibitor-insensitive proteases.
Methods and results
ANP degradation by lung membranes in either the
absence or presence of NEP inhibitors was analyzed by
thin-layer-chromatography and mass spectrometry (2).
W ef o u n dt h a tN E Pi n h i b i t i o ns t r o n g l yr e d u c e sA N P
degradation by rat and mouse but not human mem-
branes. ANP-degrading activity in human lung
membranes under conditions of NEP inhibition was
very potent and even detectable with 1 ng of membrane
protein. Like ANP, CNP was rapidly hydrolyzed. In
both peptides, initial cleavage occurred at the same
position within the conserved peptide ring structure
being essential for biological activity. A second cleavage
each was localized to the amino-terminus (behind Arg-4
or Lys-4, respectively). The cleavage sites are unrelated
to those by NEP and IDE and indicate trypsin-like
enzyme activity. Unlike ANP and CNP, BNP is a poor
substrate and shows a completely different and complex
cleavage pattern after prolonged incubation. The NEP
inhibitor-insensitive protease was also detectable, albeit
at much lower levels, in membranes from human aorta
and mesenteric arteries, but not at all in placenta. Stu-
dies with various protease inhibitors revealed that
leupeptin exposure potently inhibits NP degradation by
this activity.
Conclusion
A novel trypsin-like enzyme activity, but not NEP, is the
major natriuretic peptide-degrading membrane protease
in human lung. The accumulated expression of this
enzyme in human pulmonary tissue favours potential
therapeutic interventions in lung diseases. Leupeptin may
act as a beneficial agent in this regard.
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